comparemela.com

Latest Breaking News On - Pharma biotech - Page 10 : comparemela.com

Pharmaxis Ltd enrols first patient in clinical trial for PXS‐5505, a potential new treatment for bone marrow cancer myelofibrosis

“Its potential to modify the course of the disease by directly targeting bone marrow fibrosis will make PXS‐5505 an ideal monotherapy or adjunct to.

South koreaSouth koreanGary phillipsDrug administrationPharmaxis ltdInvestigational new drugSmall capsPharma biotechAsx pxsதெற்கு கொரியாதெற்கு கொரியன்கேரி பிலிப்ஸ்சிறிய தொப்பிகள்பார்மா பயோடெக்

Dechra Pharmaceuticals PLC expects year to be first-half weighted as pre-Brexit inventory build unwinds

The outlook for the full year remains positive, with “strong favourable” market conditions to remain

South africaUnited kingdomDechra pharmaceuticalsBig capsPharma biotechDechra pharmaceuticalLon dphஒன்றுபட்டது கிஂக்டம்டெக்ரா மருந்துகள்பெரியது தொப்பிகள்பார்மா பயோடெக்டெக்ரா மருந்துலோன் டப்

Mitre Medical gears up to treat heart disease patients in US-based study of its Mitral Touch device

Mitre Medical gears up to treat heart disease patients in US-based study of its Mitral Touch device Mitre Medical Corp CEO John MacMahon tells Proactive the privately-held group is developing a less invasive and safer approach to treat functional mitral valve regurgitation (MR) in patients with moderate to severe MR. MacMahon says the group recently announced one-year results of the group s Mitral Touch in European patients, and looks forward to bringing the technology to the US within four different clinical sites.

John macmahonMitral touchDirector interviewsPharma biotechMitre medicalPrivate na mitreஜான் மேக்மஹோன்மிட்ரல் தொடுஇயக்குனர் நேர்காணல்கள்பார்மா பயோடெக்மிடர் மருத்துவப்ரைவேட் நா மிடர்

GlaxoSmithKline PLC and Sanofi SA to push ahead with phase II trial of Covid-19 vaccine

“We are confident that our vaccine candidate has strong potential and we are very encouraged by the latest preclinical data"

United kingdomCity ofSanofi pasteurAstrazeneca oxfordThomas triompheRoger connorAziz sheikhAstrazeneca oxford universityUniversity of edinburgh usher institutePfizer biontech or astrazenecaOxford universityExecutive vice presidentUsher instituteBig capsCorona virusPharma biotech

Mountain Valley MD adds South African Variant to Bio Safety Level 4 lab study

Mountain Valley MD (CSE: MVMD- OTCQB: MVMDF) Director of Life Scienced Mike Farber joined Steve Darling from Proactive with news the company has.

South africaMountain valleyEastern capeSouth africanScienced mike farberCompany ivermectinLife scienced mike farberSteve darlingSouth african variantBiosafety levelDirector interviewsPharma biotechMountain valley md holdings incCnsx mvmdமலை பள்ளத்தாக்குகிழக்கு கேப்

vimarsana © 2020. All Rights Reserved.